Curaleaf Holdings (CURLF) Return on Assets (2020 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Return on Assets of 0.0% for Q4 2024, up 3.0% year-on-year from 0.0% in Q1 2024, and up 99.87% on a QoQ basis from 0.03% in Q3 2024.
Curaleaf Holdings (CURLF) Return on Assets (2020 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Return on Assets for 5 consecutive years, with 0.0% the latest figure, recorded in Q4 2024.
- Quarterly Return on Assets rose 3.0% year-over-year to 0.0% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.0% (up 3.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Assets rose to 0.0% in Q4 2024 per CURLF's latest filing, from 0.03% in the prior quarter.
- Over the last five years, Return on Assets for CURLF reached as high as 0.0% in Q1 2022 and fell as low as 0.03% in Q3 2024.
- A 5-year average of 0.0% and a median of 0.0% in 2020 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2023 — Return on Assets retreated 3 bps — and 2024, when it rose 3 bps.
- Year by year, Return on Assets stood at 0.0% in 2020, then surged by 96 bps to 0.0% in 2021, then slumped by 120 bps to 0.0% in 2022, then plunged by 13412 bps to 0.03% in 2023, then surged by 100 bps to 0.0% in 2024.
- According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.03%, and 0.03% for Q4 2024, Q3 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.00% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.00% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.00% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.00% |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -0.03% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |